# The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)

> **NCT00336466** · PHASE2 · COMPLETED · sponsor: **University of Calgary** · enrollment: 32 (—)

## Conditions studied

- Cardiac Surgery
- Brain Injury

## Interventions

- **DRUG:** Human recombinant erythropoietin

## Key facts

- **NCT ID:** NCT00336466
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 32 (—)
- **Last updated:** 2007-11-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336466, "The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00336466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*